Connection

Daniel Wrapp to Antibodies, Viral

Back to Details
This is a "connection" page, showing publications Daniel Wrapp has written about Antibodies, Viral.
Daniel Wrapp
Connection Strength
0.119
Antibodies, Viral
  1. The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates. Sci Transl Med. 2021 05 12; 13(593).
    View in: PubMed
    Score: 0.022
  2. Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody. Science. 2021 02 19; 371(6531):823-829.
    View in: PubMed
    Score: 0.022
  3. Broad neutralization of SARS-related viruses by human monoclonal antibodies. Science. 2020 08 07; 369(6504):731-736.
    View in: PubMed
    Score: 0.021
  4. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020 03 13; 367(6483):1260-1263.
    View in: PubMed
    Score: 0.021
  5. Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation. Immunity. 2018 02 20; 48(2):339-349.e5.
    View in: PubMed
    Score: 0.018
  6. Prolonged evolution of the human B cell response to SARS-CoV-2 infection. Sci Immunol. 2021 02 23; 6(56).
    View in: PubMed
    Score: 0.006
  7. Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape. Nat Commun. 2021 01 20; 12(1):469.
    View in: PubMed
    Score: 0.005
  8. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc Natl Acad Sci U S A. 2017 08 29; 114(35):E7348-E7357.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.